Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sarah Geoghegan"'
Autor:
Bryony Treston, Sarah Geoghegan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTRespiratory Syncytial Virus poses a significant global public health threat, particularly affecting infants aged less than one year of age. Recently, two forms of passive immunization against infant RSV have been developed and brought to mark
Externí odkaz:
https://doaj.org/article/7819eb140a3443b0a692d504af8f09e1
Autor:
Sarah Geoghegan, Jennifer Faerber, Laura Stephens, Hannah Gillan, Richard J. Drew, Maeve Eogan, Kristen A. Feemster, Karina M. Butler
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Group B Streptococcus (GBS) vaccines, designed to be given to pregnant women, are in clinical trials. There is an opportunity to conduct preparatory research now to understand the drivers of and barriers to GBS vaccine acceptance. This will enable ta
Externí odkaz:
https://doaj.org/article/4fc1bd3b679e4ccbb0f358f79120bb7f
Autor:
Katherine M Laycock, Francia Acosta, Sandra Valera, Ana Villegas, Elia Mejia, Christian Mateo, Rosa Felipe, Anabel Fernández, Megan Job, Sophia Dongas, Andrew P Steenhoff, Adam J Ratner, Sarah Geoghegan
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 9, p e0002281 (2023)
Maternal colonization with Group B Streptococcus (GBS) is an important cause of stillbirth, prematurity, and serious infection and death in infants worldwide. Resource constraints limit prevention strategies in many regions. Maternal GBS vaccines in
Externí odkaz:
https://doaj.org/article/60a0f1e5dd1747d38152d9ca5dcb7388
Autor:
Sarah Geoghegan, Laura C. Stephens, Kristen A. Feemster, Richard J. Drew, Maeve Eogan, Karina M. Butler
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 10 (2021)
Public health experts agree that pregnant women who fall into priority groups may be offered a Coronavirus Disease 2019 (COVID-19) vaccine. However, little is known about attitudes of pregnant women toward COVID-19 vaccination. We surveyed 300 pregna
Externí odkaz:
https://doaj.org/article/f3b76dc66cea494787e30a73c9ad501e
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
The World Health Organization has named vaccine hesitancy as one of the top ten threats to global health in 2019. The reasons why people choose not to vaccinate are complex, but lack of confidence in vaccine safety, driven by concerns about adverse e
Externí odkaz:
https://doaj.org/article/68d749704fc944e0b56b19378f85a830
Autor:
Sarah Geoghegan, Francia Acosta, Laura C. Stephens, Hanah Gillan, Sandra Valera, Richard J. Drew, Maeve Eogan, Adam J. Ratner, Andrew P. Steenhoff, Karina M. Butler, Kristen A. Feemster
Publikováno v:
Vaccine. 41:2013-2021
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d6c7411e4571e174428b3c783f3bda3
https://doi.org/10.1016/j.vaccine.2023.02.037
https://doi.org/10.1016/j.vaccine.2023.02.037
Publikováno v:
Maternal and child health journal. 26(11)
Vaccines are being developed against Group B Streptococcus and respiratory syncytial virus. These vaccines are designed to be given to pregnant women to protect infants; thus, their success depends on uptake in this population. Maternal immunization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::430b1fba1ddee1dd649000afa314201a
https://pubmed.ncbi.nlm.nih.gov/36173503
https://pubmed.ncbi.nlm.nih.gov/36173503
Autor:
Laura C. Stephens, Sarah Geoghegan, Richard J. Drew, Kristen A. Feemster, Karina Butler, Maeve Eogan
Publikováno v:
Hum Vaccin Immunother
Public health experts agree that pregnant women who fall into priority groups may be offered a Coronavirus Disease 2019 (COVID-19) vaccine. However, little is known about attitudes of pregnant women toward COVID-19 vaccination. We surveyed 300 pregna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6ea72cf334051931b1a61a230fbe98
https://doi.org/10.1080/21645515.2021.1924018
https://doi.org/10.1080/21645515.2021.1924018
Autor:
Rebecca M. Harris, Susan E. Coffin, Xianqun Luan, Leila C Posch, Audrey R. Odom John, Sarah Geoghegan, Jeffrey S. Gerber, Julia S. Sammons, William R Otto, Louis M. Bell
Publikováno v:
Journal of the Pediatric Infectious Diseases Society
BackgroundUnderstanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic.MethodsThis was a retrospective case series of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233e403c7a502851aa495fc3c5bac63d
http://europepmc.org/articles/PMC7337783
http://europepmc.org/articles/PMC7337783
Autor:
Fernando P. Polack, Evan L. O'Keefe, Courtney McCracken, Patricio L. Acosta, Curtis Travers, Mauricio T. Caballero, Devi Rajan, Sarah Geoghegan, Larry J. Anderson
Publikováno v:
Clinical Infectious Diseases. 67:1441-1444
To assess MUC5AC as a biomarker for respiratory syncytial virus (RSV) disease severity, we tested nasal aspirates from RSV+ children with mild, moderate, and severe disease. Levels were significantly higher in those in the severe and moderate groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34fe606236119059ee779f8dbfebadc7
https://doi.org/10.1093/cid/ciy340
https://doi.org/10.1093/cid/ciy340